Illumina Inc (ILMN)

pos +0.00
Today's Range: 0.00 - 0.00 | ILMN Avg Daily Volume: 1,694,700
Last Update: 07/22/14 - 4:00 PM EDT
Volume: 0
YTD Performance: 59.43%
Open: $0.00
Previous Close: $176.31
52 Week Range: $72.77 - $184.49
Oustanding Shares: 128,400,000
Market Cap: 21,967,956,000
6-Month Chart
TheStreet Ratings Grade for ILMN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 7
Moderate Buy 0 0 0 0
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.94 1.94 1.94 2.07
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 118.84
Price Earnings Comparisons:
ILMN Sector Avg. S&P 500
118.84 117.80 28.87
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
19.14% 135.93% 136.75%
Revenue 23.70 0.57 0.16
Net Income -17.20 0.00 0.00
EPS -20.90 -0.01 0.00
Earnings for ILMN:
Revenue 1.42B
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $0.51 $0.52 $2.16 $2.65
Number of Analysts 12 11 13 12
High Estimate $0.52 $0.54 $2.21 $2.80
Low Estimate $0.48 $0.50 $2.12 $2.54
Prior Year $0.43 $0.45 $1.80 $2.16
Growth Rate (Year over Year) 17.64% 15.76% 19.96% 22.50%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Apr 23, 2014 | 8:11 AM EDT
ILMN was upgraded from Hold to Buy, Maxim Group said. $205 price target. Clinical customers are accelerating adoption and the company i...

That Was the Week That Was Real Money Pro($)

Let's review.
I'd wait until the stock cools off to buy shares.
Its genetics work has the stock at crazy new heights
Feb 19, 2014 | 7:33 AM EST
ILMN raised its numbers through 2016, UBS said. Demand momentum and competitive position appear stronger than ever. $202 price target a...
Jan 17, 2014 | 8:17 AM EST
ILMN was placed on the Focus List, JP Morgan said. $190 price target. Company will launch several new products this year. Overweight ra...
Washington will offer mixed bag answers to key policy questions.
Oct 22, 2013 | 8:15 AM EDT
ILMN estimates were boosted through 2015, Credit Suisse said. Company raised its guidance. Outperform rating and new $95 price target.&...
All we're waiting on is the buy trigger.
Aug 22, 2013 | 8:05 AM EDT
Shares of ILMN now seen reaching $90, according to Bank of America/Merrill Lynch said. Estimates also increased, given higher HiSeq gro...

Columnist Conversations

We are currently testing the key resistance decision in ICE. Do not consider an entry without a trigger!! ...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
EA reported June revenue of $775 mlm vs. $714 est. much better than expected. EPS of $0.19 blew away the St es...
BIDU still has some higher targets, but it's a good idea to TRAIL UP stops when you EXTEND the prior swings. ...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.